Imidazole → HCID 67388345, compound
Reaction equation
[C:1]([Si:5]([CH3:8])([CH3:7])Cl)([CH3:4])([CH3:3])[CH3:2].[OH:9][C@@H:10]1[C:15](=[O:16])[CH:14]=[CH:13][C@@H:12]([O:17][CH2:18][C:19]2[CH:24]=[CH:23][C:22]([O:25][CH3:26])=[CH:21][CH:20]=2)[CH2:11]1.N1C=CN=C1>CN(C)C=O>[Si:5]([O:9][C@@H:10]1[C:15](=[O:16])[CH:14]=[CH:13][C@@H:12]([O:17][CH2:18][C:19]2[CH:20]=[CH:21][C:22]([O:25][CH3:26])=[CH:23][CH:24]=2)[CH2:11]1)([C:1]([CH3:4])([CH3:3])[CH3:2])([CH3:8])[CH3:7]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
tert-Butyldimethychlorosilane (26 mg, 0.18 mmol, 1.5 equiv) was added to an ice-cooled solution of (4S,6S)-6-hydroxy-4-(4-methoxybenzyloxy)cyclohex-2-enone (29 mg, 0.12 mmol, 1 equiv) and imidazole (24 mg, 0.35 mmol, 3 equiv) in dimethylformamide (0.5 mL). After 45 min, the reaction mixture was partitioned between water (15 mL), saturated aqueous sodium chloride solution (15 mL), and ethyl acetate (20 mL). The layers were separated. The organic layer was washed with water (2×20 mL) and the washed solution was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography to provide 29 mg of the product, (4S,6S)-6-(tert-butyldimethylsilyloxy)-4-(4-methoxybenzyloxy)cyclohex-2-enone, as a colorless oil (87%).
Workup
- customthe reaction mixture was partitioned between water (15 mL), saturated aqueous sodium chloride solution (15 mL), and ethyl acetate (20 mL)
- customThe layers were separated
- washThe organic layer was washed with water (2×20 mL)
- dry with materialthe washed solution was dried over sodium sulfate
- filtrationThe dried solution was filtered
- concentrationthe filtrate was concentrated
- customThe residue was purified by flash-column chromatography
Sources & evidence
- ORD record
- ord-277ab8d6dd864aae8cead0a5009e4e3e
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09102697B2
Reaction notes
Loading…